The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination

被引:6
作者
Bondt, Patricia E. Vermeer-de [1 ]
van der Maas, Nicoline A. T. [1 ]
机构
[1] RIVM, Natl Vaccinat Programme, Safety Surveillance & Consultat Serv, Bilthoven, Netherlands
关键词
adverse event following immunization (AEFI); collapse; hypotonic-hyporesponsive episode; pertussis vaccine;
D O I
10.1097/INF.0b013e318162a127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Netherlands vaccination schedule has been advanced by I month. The reporting rate of collapse or hypotonic-hyporesponsive episode increased from 5.2 [95% confidence interval (CI): 4.8-5.7] to 8.5 (95% CI: 8.0-9.1) and from 1.2 (95% CI: 1.0-1.4) to 2.5 (95% CI: 2.2-2.8) per 10,000 first and second doses, respectively. At 3 months of age it fell from 5.2 to 2.5. This suggests some protection by the first dose. Different mediators in primary and secondary immune response may play a role.
引用
收藏
页码:355 / 357
页数:3
相关论文
共 15 条
[1]  
BLUMBERG DA, 1991, DEV BIOLOGICALS, V73, P289
[2]   Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation [J].
Bonhoeffer, J ;
Gold, MS ;
Heijbel, H ;
Vermeer, P ;
Blumberg, D ;
Braun, M ;
de Souza-Brito, G ;
Davis, RL ;
Halperin, S ;
Heininger, U ;
Khuri-Bulos, N ;
Menkes, J ;
Nokleby, H .
VACCINE, 2004, 22 (5-6) :563-568
[3]   Report of a US Public Health Service Workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization [J].
Braun, MM ;
Terracciano, G ;
Salive, ME ;
Blumberg, DA ;
Vermeer-de Bondt, PE ;
Heijbel, H ;
Evans, G ;
Patriarca, PA ;
Ellenberg, SS .
PEDIATRICS, 1998, 102 (05)
[4]   Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation [J].
Buettcher, Michael ;
Heininger, Ulrich ;
Braun, Miles ;
Bonhoeffer, Jan ;
Halperin, Scott ;
Heijbel, Harald ;
Martins, Reinaldo de Menezes ;
Vermeer-de Bondt, Patricia .
VACCINE, 2007, 25 (31) :5875-5881
[5]  
CODY CL, 1981, PEDIATRICS, V68, P650
[6]  
HANNIK CA, 1979, P 3 INT S PERT BETHS, V79, P279
[7]  
Heijbel H, 1997, DEV BIOL STAND, V89, P101
[8]  
MAASVANDER N, IN PRESS NED TIJDSCH
[9]  
MAASVANDER N, 2006, ADVERSE EVENTS FOLLO
[10]  
RUMKE HC, 1999, TIJDSCHR JEUGDGEZOND, V31, P2